Co-expression of HER3 and MUC1 is associated with a favourable prognosis in patients with bladder cancer
Author:
Affiliation:
1. Department of Clinical Biochemistry; Aarhus University Hospital; Aarhus Denmark
2. Department of Urology; Aarhus University Hospital; Aarhus Denmark
Funder
Danish Cancer Society
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12658/fullpdf
Reference7 articles.
1. ErbB receptors and signaling pathways in cancer;Hynes;Curr Opin Cell Biol,2009
2. Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients;Memon;Br J Cancer,2004
3. MUC1 mucin in urological malignancy;Scholfield;BJU Int,2003
4. The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients;Memon;Br J Cancer,2006
5. Structure, evolution, and biology of the MUC4 mucin;Chaturvedi;FASEB J,2008
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance;Cancer Letters;2024-09
2. Altered Glycosylation in Progression and Management of Bladder Cancer;Molecules;2023-04-13
3. Changes in HER3 expression profiles between primary and recurrent gynecological cancers;Cancer Cell International;2023-02-03
4. HER3 Alterations in Cancer and Potential Clinical Implications;Cancers;2022-12-14
5. Changes in HER3 expression profiles between primary and recurrent gynecological cancers;2022-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3